Latest news

The NIHR-supported RECOVERY-RS trial has demonstrated that treating hospitalised COVID-19 patients who have acute respiratory failure with continuous positive airway pressure (CPAP) reduces the need for invasive mechanical ventilation.
- Published:
05 August 2021

Three international trial platforms have found that blood thinners improve survival and reduces the need for vital organ support such as mechanical ventilation in moderately ill patients with COVID-19.
- Published:
05 August 2021

The Good Clinical Trials Collaborative has launched a 6-week consultation on new guidance for the conduct and regulation of randomised controlled trials (RCTs).
- Published:
04 August 2021

Professor Lucy Chappell has today taken up her new post as Chief Executive of the NIHR.
- Published:
02 August 2021

Researchers assessing long-term changes in the brain in professional rugby players found almost half showed an unexpected reduction in brain volume and nearly a quarter displayed abnormalities in brain structure.

People experiencing long COVID will benefit from a comprehensive package of new NIHR-funded research to help improve the understanding of the condition, from diagnosis and treatment through to rehabilitation and recovery.

A large-scale, NIHR-supported observational study has found that one in two people hospitalised with COVID-19 developed at least one health complication as a result of the viral infection.

NIHR-funded researchers have launched a blueprint highlighting innovative ways and best practice for using fully consented patient data in clinical trials for public benefit.

People who experience five or more symptoms of COVID-19 in the first week of infection are more likely to develop long-term health problems, irrespective of age or gender, according to a new review of research on long COVID.

The latest NIHR Clinical Research Network (CRN) annual statistics show the extraordinary impact the organisation made in delivering vital clinical research during the 2020/21 pandemic.

A study funded by the NIHR has discovered little difference in the clinical effectiveness of two treatments for ankle fractures, the traditional cast and the removable brace.

The winners of the very first British Society of Gastroenterology and NIHR Clinical Research Network (BSG/NIHR CRN) research awards have been announced.

The NIHR and Charities Consortium Hospice and Community Research are delighted to announce the winners of the 2021 NIHR and Charities Consortium Hospice and Community Research - Hospice Consortium Prizes.

A new £1.6 million NIHR-funded study will compare the benefits of knee replacement surgery performed using a robot to a surgeon using traditional methods.

Researchers leading an NIHR-funded study investigating cancer diagnosis and care in English prisons have highlighted the importance of former prisoners’ providing their ‘lived experience’ in shaping their work.

The first participants in the world have been vaccinated using a Oxford/AstraZeneca variant vaccine, aimed at preventing the Beta COVID-19 variant.

Alternating doses of the Oxford/AstraZeneca and Pfizer vaccines generate robust immune responses against COVID-19, an NIHR supported study has found. The Com-COV study is led by the University of Oxford and run across eight NIHR sites in the UK.

Up to one in three people who report being infected by SARS-CoV-2 also report long COVID symptoms, with older people and women more likely to be affected.

Following publication of the ‘Saving and improving lives: the future of UK clinical research delivery’ vision in March, the UK government and devolved administrations today set out the first phase of activity.

Researchers, study participants and members of the public are today recognising the efforts of all of those involved in COVID-19 research, by supporting the #Red4Research campaign.

Nearly a third of patients admitted to hospital with suspected COVID-19 during the first wave of the pandemic had a ‘Do Not Attempt Cardiopulmonary Resuscitation’ (DNACPR) decision recorded before, or on their day of admission to hospital, finds new NIHR-funded research.

A monoclonal antibody combination can help save lives of hospitalised patients with severe COVID-19 who were unable to generate an antibody response of their own before beginning treatment.

NIHR, in partnership with NHSX and Accelerated Access Collaborative (AAC), have today announced a £36 million funding boost for artificial intelligence (AI) technologies to benefit thousands of patients.

Many common dental procedures have a very low risk of increasing the aerosol spread of COVID-19, suggests new research funded by NIHR and UKRI.

The NIHR is delighted to announce that several prominent members of the NIHR family have received awards from Her Majesty Queen Elizabeth II as part of her birthday honours.